Patterns of mental health symptoms among women living with HIV ages 45-60 in England: associations with demographic and clinical factors

Abstract

Objective: We aimed to describe the prevalence of various mental health symptoms according to menopausal status (pre, peri, post) among women living with HIV ages 45-60 in England, and to identify groups of women with similar general and menopause-related mental health symptoms. We then investigated demographic predictors of group-membership and group differences in HIV-related care outcomes (antiretroviral therapy adherence, HIV clinic attendance, CD4-count, and last HIV viral load).Methods: An analysis of cross-sectional data from the Positive Transitions through Menopause study, an observational study of the health and well-being impacts of menopause on 869 women with HIV aged 45-60 years. Self-reported data on eight mental health indicators were collected from women in pre-, peri-and post-menopausal state using validated measures. Groups (termed ''classes'') of women with similar mental health symptoms were derived via latent class analysis. Class membership was linked to demographic factors using nominal logistic regression, and to clinical outcomes using Wald tests.Results: We identified five classes: 1) few mental health symptoms (n ¼ 501, 57.8%); 2) high current anxiety/ depression (n ¼ 120, 13.8%); 3) history of depression, with elevated current substance use (n ¼ 40, 4.6%); 4) history of depression with current psychological menopause symptoms (n ¼ 81, 9.3%); and 5) high previous and concurrent mental health problems (n ¼ 125, 14.4%). University attendance, ethnicity, and longer time since HIV diagnosis predicted class membership. Antiretroviral therapy adherence was lower in classes 3 (11%), 4 (19%) and 5 (24%) compared to class 1 (4%; all P < 0.001). Members of class 5 were more likely to have missed !1 HIV clinic appointment in the past year than those in class 1 (34% vs 17%, P ¼ 0.005).Conclusions: Women with a history of depression, current anxiety/depression, and current menopause-related mental health symptoms were more likely to have poorer clinical outcomes. Although we cannot comment on causality, our findings highlight the importance of assessing and managing menopausal symptoms and mental health to improve well-being and engagement in HIV care.